DK1037640T3 - Indgivelse af produkter fra 5-lipoxygenase-metabolismepathway'en til forstærkning af antimikrobielt forsvar - Google Patents

Indgivelse af produkter fra 5-lipoxygenase-metabolismepathway'en til forstærkning af antimikrobielt forsvar

Info

Publication number
DK1037640T3
DK1037640T3 DK97954070T DK97954070T DK1037640T3 DK 1037640 T3 DK1037640 T3 DK 1037640T3 DK 97954070 T DK97954070 T DK 97954070T DK 97954070 T DK97954070 T DK 97954070T DK 1037640 T3 DK1037640 T3 DK 1037640T3
Authority
DK
Denmark
Prior art keywords
products
administration
metabolism pathway
enhance antimicrobial
antimicrobial defense
Prior art date
Application number
DK97954070T
Other languages
Danish (da)
English (en)
Inventor
Marc Peters-Golden
Theodore Standiford
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of DK1037640T3 publication Critical patent/DK1037640T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97954070T 1996-12-03 1997-12-03 Indgivelse af produkter fra 5-lipoxygenase-metabolismepathway'en til forstærkning af antimikrobielt forsvar DK1037640T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/757,136 US5909734A (en) 1996-12-03 1996-12-03 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense

Publications (1)

Publication Number Publication Date
DK1037640T3 true DK1037640T3 (da) 2006-03-13

Family

ID=25046516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97954070T DK1037640T3 (da) 1996-12-03 1997-12-03 Indgivelse af produkter fra 5-lipoxygenase-metabolismepathway'en til forstærkning af antimikrobielt forsvar

Country Status (9)

Country Link
US (3) US5909734A (fr)
EP (2) EP1037640B1 (fr)
AT (2) ATE307589T1 (fr)
AU (1) AU733567B2 (fr)
CA (1) CA2278140C (fr)
DE (2) DE69734476T2 (fr)
DK (1) DK1037640T3 (fr)
ES (2) ES2341255T3 (fr)
WO (1) WO1998024397A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473708B2 (en) 1996-02-15 2009-01-06 Jean Gosselin Agents with leukotriene B4-like antiviral (enveloped RNA) activities
US5909734A (en) * 1996-12-03 1999-06-08 Regents Of The University Of Michigan Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
KR100325581B1 (ko) * 1998-08-07 2002-08-24 오우택 아라키토닉산의리폭시게네이즈대사결과물질을함유하는진통제용조성물
WO2004112795A1 (fr) * 2003-06-25 2004-12-29 Ltb4 Sweden Ab Compositions de ltb4 pour le traitement d'infections du tractus respiratoire
WO2005102309A2 (fr) * 2004-04-26 2005-11-03 Ltb4 Sweden Ab Liberation in vivo de mediateurs endogenes antimicrobiens par administration de leukotriene b4 (ltb4)
CN101039698B (zh) * 2004-09-20 2011-11-09 Ltb4瑞典公司 稳定的白三烯b4(ltb4)药剂的药学配方
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN112546196A (zh) * 2020-02-29 2021-03-26 中国人民解放军总医院第三医学中心 肌动蛋白聚合诱导剂在制备抵抗或抑制肺炎克雷伯氏菌的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4821714A (en) * 1986-12-04 1989-04-18 Smelser Danny N Pharmaceutical endotracheal tube
US5314918A (en) * 1987-06-24 1994-05-24 Smithkline Beecham Corporation Leukotriene antagonists
US5145861A (en) * 1987-11-04 1992-09-08 Merrell Dow Pharmaceuticals Inc. Fluorinated arachidonic acid derivatives
AU667300B2 (en) * 1992-03-07 1996-03-21 Morinaga Milk Industry Company Limited Immunostimulatory peptide from lactoferrin
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
US5789441A (en) * 1996-02-15 1998-08-04 Virocell Inc. Leukotriene B4 as an antiviral and anti-neoplastic agent
US5909734A (en) * 1996-12-03 1999-06-08 Regents Of The University Of Michigan Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense

Also Published As

Publication number Publication date
ATE307589T1 (de) 2005-11-15
EP1602375A3 (fr) 2005-12-14
EP1602375B1 (fr) 2010-02-17
CA2278140C (fr) 2008-02-05
US20050267211A1 (en) 2005-12-01
DE69739775D1 (de) 2010-04-01
CA2278140A1 (fr) 1998-06-11
WO1998024397A2 (fr) 1998-06-11
US7696148B1 (en) 2010-04-13
US5909734A (en) 1999-06-08
EP1037640B1 (fr) 2005-10-26
WO1998024397A3 (fr) 1998-09-03
EP1037640A4 (fr) 2003-07-23
ES2341255T3 (es) 2010-06-17
DE69734476D1 (de) 2005-12-01
AU733567B2 (en) 2001-05-17
ES2251748T3 (es) 2006-05-01
ATE457730T1 (de) 2010-03-15
EP1602375A2 (fr) 2005-12-07
DE69734476T2 (de) 2006-07-13
AU5794298A (en) 1998-06-29
EP1037640A2 (fr) 2000-09-27

Similar Documents

Publication Publication Date Title
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
IL106842A (en) Pharmaceutical compositions comprising il-4r or derivatives thereof for the treatment, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and fungal infections
AU1794601A (en) Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
AU2002211536A1 (en) Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
EE9700269A (et) Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini
DK1037640T3 (da) Indgivelse af produkter fra 5-lipoxygenase-metabolismepathway'en til forstærkning af antimikrobielt forsvar
EP1013282A3 (fr) Compositions pharmaceutiques et alimentaires contenant des transferrines et des agents antibactériens pour améliorer l'activité des dépenses immunitaires et pour le traitement d'infections
SE9201930D0 (sv) Gastric antibacterial treatment
MX9708611A (es) Compuestos de dialquiltiacumicina.
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
ES2136206T3 (es) Composicion antibacteriana que contiene alfalactalbumina multimerica.
IL124733A0 (en) Composition for organ cryopreservation and treatment of viral and bacterial infections
WO2000016786A3 (fr) Acide oxihumique et son utilisation dans le traitement de diverses conditions
ME00858B (me) UPOTREBA 8a-AZALIDA U VETERINI KAO ANTIMIKROBNA SREDSTVA
ZA946489B (en) Novel treatment of upper respiratory tract infections
AU2466399A (en) Compositions for prevention and treatment of cold and influenza-like symptoms associated with respiratory tract infections
RU94024111A (ru) Способ профилактики кишечных инфекций
Zhang The clinical study of cefamandole nafate.
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.
HUP9902828A3 (en) Pharmaceutical composition for killing antibiotic-resistant gram positive bacteria and treatment of infection
HUP0001161A3 (en) Composition for organ cryopreservation and treatment of viral and bacterial infections
LT98090A (en) Composition for organ cryopreservation and treatment of viral and bacterial infections
AU1007401A (en) Treatment of respiratory diseases and infections
ZA948741B (en) Novel treatment of upper respiratory tract infections